SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 60 filers reported holding SERES THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,923,000 | -10.6% | 1,103,382 | +11.0% | 0.00% | -33.3% |
| Q3 2016 | $12,218,000 | -54.7% | 994,119 | +7.2% | 0.00% | -50.0% |
| Q2 2016 | $26,943,000 | +41.6% | 927,471 | +29.4% | 0.01% | +50.0% |
| Q1 2016 | $19,031,000 | -18.1% | 716,515 | +8.2% | 0.00% | -20.0% |
| Q4 2015 | $23,232,000 | +282.8% | 662,077 | +223.3% | 0.01% | +150.0% |
| Q3 2015 | $6,069,000 | – | 204,769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |